686 related articles for article (PubMed ID: 16049991)
1. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Down syndrome in Glasgow, 1980-96--the growing impact of prenatal diagnosis on younger mothers.
Iliyasu Z; Gilmour WH; Stone DH
Health Bull (Edinb); 2002 Jan; 60(1):20-6. PubMed ID: 12664764
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
Colvin J; Bower C; Dickinson JE; Sokol J
Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
[TBL] [Abstract][Full Text] [Related]
4. Prenatal testing for Down syndrome in the Jewish and non-Jewish populations in Israel.
Davidov B; Goldman B; Akstein E; Barkai G; Legum C; Dar H; Romem Y; Amiel A; Cohen H; Bach G
Isr J Med Sci; 1994 Aug; 30(8):629-33. PubMed ID: 8045747
[TBL] [Abstract][Full Text] [Related]
5. [Prenatal diagnosis of Down syndrome in Denmark 1980-1998 and future progress perspectives].
Larsen SO; Hansen J; Christiansen M; Nørgaard-Pedersen B
Ugeskr Laeger; 2002 Sep; 164(39):4532-6. PubMed ID: 12380396
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women.
Hwa HL; Yen MF; Lin CL; Ko TM; Hsieh FJ; Chen TH
J Eval Clin Pract; 2008 Apr; 14(2):191-7. PubMed ID: 18284525
[TBL] [Abstract][Full Text] [Related]
7. Maternal age-specific risk of Down syndrome in an Asian population: a report of the Taiwan Down Syndrome Screening Group.
Sheu BC; Shyu MK; Lee CN; Kuo BJ; Tseng YY; Hsieh FJ
Prenat Diagn; 1998 Jul; 18(7):675-82. PubMed ID: 9706648
[TBL] [Abstract][Full Text] [Related]
8. [Study on key techniques and intervention in reducing birth defects].
Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
[TBL] [Abstract][Full Text] [Related]
9. First- and second-trimester Down syndrome screening: current strategies and clinical guidelines.
Shaw SW; Hsu JJ; Lee CN; Hsiao CH; Chen CP; Hsieh TT; Cheng PJ
Taiwan J Obstet Gynecol; 2008 Jun; 47(2):157-62. PubMed ID: 18603499
[TBL] [Abstract][Full Text] [Related]
10. Risk of a Down syndrome live birth in women 45 years of age and older.
Morris JK; De Vigan C; Mutton DE; Alberman E
Prenat Diagn; 2005 Apr; 25(4):275-8. PubMed ID: 15849789
[TBL] [Abstract][Full Text] [Related]
11. Screening advances and diagnostic choice: the problem of residual risk.
Henry GP; Britt DW; Evans MI
Fetal Diagn Ther; 2008; 23(4):308-15. PubMed ID: 18417998
[TBL] [Abstract][Full Text] [Related]
12. First- and second-trimester evaluation of risk for Down syndrome.
Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
[TBL] [Abstract][Full Text] [Related]
13. [Maternal serum screening for Down syndrome and neural tube defects].
van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
[TBL] [Abstract][Full Text] [Related]
14. Down syndrome screening in Singapore--the effectiveness of a second trimester serum screening policy modelled on 29,360 pregnancies in KK Women's and Children's Hospital.
Lai FM; Yeo GS
Singapore Med J; 1998 Feb; 39(2):69-75. PubMed ID: 9652180
[TBL] [Abstract][Full Text] [Related]
15. Is Down syndrome a disappearing birth defect?
Collins VR; Muggli EE; Riley M; Palma S; Halliday JL
J Pediatr; 2008 Jan; 152(1):20-4, 24.e1. PubMed ID: 18154892
[TBL] [Abstract][Full Text] [Related]
16. Descriptive epidemiology of Down's syndrome in Estonia.
Reimand T; Ounap K; Zordania R; Ilus T; Uibo O; Sitska M; Talvik T
Paediatr Perinat Epidemiol; 2006 Nov; 20(6):512-9. PubMed ID: 17052289
[TBL] [Abstract][Full Text] [Related]
17. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
Sritippayawan S; Vachirasrisoontra C
J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
[TBL] [Abstract][Full Text] [Related]
18. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study.
Weijerman ME; van Furth AM; Vonk Noordegraaf A; van Wouwe JP; Broers CJ; Gemke RJ
J Pediatr; 2008 Jan; 152(1):15-9. PubMed ID: 18154890
[TBL] [Abstract][Full Text] [Related]
20. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
